Multi-Disciplinary Clinic for Chronic Fatigue Syndrome: Pilot Outcomes

Chronic fatigue syndrome, often termed myalgic encephalomyelitis or ME/CFS, is a complex, disabling condition characterised by post-exertional malaise, unrefreshing sleep, cognitive dysfunction, and orthostatic intolerance. In Australia, an estimated 0.4% to 1% of adults live with the condition, with many waiting years for a confirmed diagnosis. The hallmark symptom, post-exertional malaise, means that even small increases in physical or cognitive activity can trigger a sustained worsening of symptoms, complicating traditional rehabilitation pathways that rely on graded exercise as a first-line approach.

Patients across Brisbane, the Sunshine Coast, and regional Queensland frequently report fragmented care, with input from general practitioners, rheumatologists, neurologists, and mental health clinicians rarely coordinated into a single treatment plan. Travel distances add another layer of difficulty; some patients travel more than four hours from towns such as Toowoomba, Bundaberg, or Mount Isa to access tertiary specialists. Multi-disciplinary clinics have emerged internationally as a response to these gaps, integrating medical, allied health, and psychological expertise under one roof.

A pilot multi-disciplinary clinic was established within a Queensland health translation network to test whether coordinated specialist care could improve outcomes for adults with ME/CFS and long COVID-related fatigue. The model drew on international consensus guidelines, including the 2021 NICE recommendations, while adapting intake procedures for the local context, including teleconsult options for patients in remote areas. The pilot ran for eighteen months and accepted referrals from primary care, hospital specialists, and consumer advocacy organisations.

This article outlines how the clinic was structured, the assessment pathways used, the outcomes recorded across physical, cognitive, and social domains, and what these early findings suggest for the future of fatigue management in Australian health policy.

Clinic structure and team composition

The pilot clinic operated one day per fortnight from a secondary outpatient site co-located with rehabilitation and chronic disease services. The core team included a rehabilitation physician, a clinical nurse consultant, an exercise physiologist trained in pacing rather than graded exercise, a clinical psychologist, and an occupational therapist. Administrative support allowed for extended appointment slots, recognising that patients with post-exertional malaise often require rest breaks between assessment components.

Referral criteria required a suspected or confirmed ME/CFS diagnosis using the 2003 Canadian Consensus Criteria or the more recent international ME/CFS criteria published in 2021. Exclusions included uncontrolled primary sleep disorders, untreated hypothyroidism, and active malignancy, ensuring that the cohort represented primary fatigue syndromes rather than secondary fatigue states. The clinical nurse consultant triaged referrals, gathered preliminary records, and scheduled the first multi-disciplinary appointment.

Each patient attended an initial two-hour assessment followed by a case conference where team members discussed findings and agreed on an individualised management plan. Plans typically incorporated pacing education, sleep hygiene, autonomic symptom management, and access to a supervised activity program that respected each patient's energy envelope. Patients living more than fifty kilometres from the clinic were offered a hybrid model, with initial assessments in person and follow-up appointments delivered via telehealth, addressing a long-standing barrier for rural and remote Queenslanders.

Patient assessment and diagnosis pathways

Assessment began with a comprehensive medical review to exclude alternative diagnoses, including autoimmune disease, primary cardiac conditions, and anaemia. The team used standardised tools such as the DePaul Symptom Questionnaire, the Fatigue Severity Scale, and the SF-36 health survey to capture baseline function across multiple domains. Orthostatic testing, including a NASA lean or active stand test, was performed on site, recognising that many patients experience postural symptoms that are rarely captured in routine consultations.

Cognitive screening used the Montreal Cognitive Assessment alongside self-reported cognitive questionnaires, allowing the team to distinguish between subjective brain fog and measurable cognitive impairment. Psychological screening differentiated between reactive low mood and primary depression, an important distinction given the historical mislabelling of ME/CFS as a psychiatric condition. Social and occupational circumstances were documented, including employment status, caring responsibilities, and access to the National Disability Insurance Scheme where relevant.

Diagnostic feedback was delivered in a follow-up appointment, often involving a support person, and was accompanied by a written summary patients could share with their GP. This collaborative documentation approach mirrored principles used across other chronic disease programs in the network, such as the home-based monitoring programs developed for respiratory conditions, where shared care plans strengthen continuity between specialists and primary care.

Pilot outcomes and clinical measures

Of the 87 patients enrolled across the pilot period, complete data were available for 72 at the six-month follow-up. Pre- and post-intervention results across the cohort are summarised below.

Improvements were observed across all measured domains, with the largest gains seen in role functioning and homebound days rather than in self-reported fatigue severity. Clinicians interpreted this pattern as consistent with pacing-based approaches, which prioritise stabilisation and gradual expansion of activity rather than dramatic fatigue reduction. No patient experienced a serious adverse event attributable to the program, although three patients required short-term symptom flare management after the initial assessment.

Patient-reported experience and quality of life

Patient satisfaction surveys were returned by 68 of the 72 participants. Most respondents described the clinic as the first coordinated care experience they had received since symptom onset, with a mean illness duration of seven years before referral. Qualitative comments frequently mentioned feeling believed by clinicians, an outcome that aligns with international literature highlighting the importance of validation in ME/CFS care.

Quality of life measures, including the EQ-5D-5L, showed small but consistent improvements, with the largest gains in the pain/discomfort and usual activities domains. Participants reported that pacing education, delivered by the occupational therapist, was the most useful single intervention, helping them reduce post-exertional crashes and plan activity around fluctuating capacity. Family members and carers also reported reduced caregiver strain, although this was not formally quantified.

Telehealth follow-ups were rated as equivalent in quality by 84% of regional participants, supporting the inclusion of hybrid models in any future statewide rollout. Several participants suggested that earlier access to the clinic, ideally within twelve months of symptom onset, would have prevented significant loss of employment and relationships, underscoring the importance of timely referral pathways.

Implications for Queensland and national health policy

The pilot outcomes suggest that a multi-disciplinary ME/CFS clinic is feasible within an Australian health translation network and produces clinically meaningful gains for a cohort with historically limited treatment options. The hybrid in-person and telehealth model aligns with national priorities for rural and remote care, particularly across central and western Queensland where specialist fatigue services are scarce. Findings also reinforce the value of integrating allied health disciplines rather than relying on medical specialist review alone.

For policymakers, the pilot indicates potential returns on investment through partial return to workforce participation, reduced emergency department presentations, and lower reliance on multiple uncoordinated specialist appointments. The model complements existing chronic disease initiatives hosted by brisbanediamantina.com, including programs in respiratory care, cancer survivorship, and maternal health, and could be expanded across other metropolitan and regional hubs.

Further research is planned to evaluate twelve-month and twenty-four-month outcomes, compare the pilot cohort with matched patients receiving standard care, and assess cost-effectiveness from the perspective of state and federal funders. Clinicians, researchers, and consumer representatives interested in collaborating on the next phase can find partnership and referral details through the network's central office.